Diagnostic utility of plasma lncRNA small nucleolar RNA host gene 1 in patients with hepatocellular carcinoma

Gao,Shoubao; Xu,Xiaohong; Wang,Yue; Zhang,Wei; Wang,Xingye

doi:10.3892/mmr.2018.9336

Diagnostic utility of plasma lncRNA small nucleolar RNA host gene 1 in patients with hepatocellular carcinoma

Authors:
- Shoubao Gao
- Xiaohong Xu
- Yue Wang
- Wei Zhang
- Xingye Wang
View Affiliations

Affiliations: Department of Oncology, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, Heilongjiang 161021, P.R. China, Department of Clinical Laboratory, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, Heilongjiang 161021, P.R. China, Medical School of Nanchang University, Nanchang, Jiangxi 330031, P.R. China
Published online on: July 30, 2018 https://doi.org/10.3892/mmr.2018.9336
Pages: 3305-3313
Copyright: © Gao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Long non‑coding RNAs (lncRNAs) offer great potential as cancer biomarkers. Owing to the limited sensitivity and specificity of α‑fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma (HCC), the present study used an lncRNA microarray to screen aberrantly expressed lncRNAs in HCC tissues. Subsequently, the expression profile of the target lncRNAs was investigated in plasma from patients with HCC or hepatitis B virus‑positive chronic hepatitis and cirrhosis (HCH), as well as from healthy volunteers. A total of six aberrantly expressed lncRNAs were identified in HCC tissues and corresponding normal tissues, from which only small nucleolar RNA host gene 1 (SNHG1) expression in HCC tissues demonstrated a good correlation with those in plasma from HCC patients. Subsequent analysis revealed that high plasma SNHG1 expression levels were correlated with tumor size, TNM stage and AFP levels. Receiver operating characteristic analysis demonstrated that SNHG1 yields an excellent diagnostic ability to differentiate between patients with HCC and unaffected control patients, which was superior to that of AFP. The combination of SNHG1 with AFP may be able to distinguish HCC from HCH or healthy volunteers with the area under the curve values of 0.86 and 0.97, respectively. In summary, it was demonstrated that plasma SNHG1 has great potential as a sensitive and reliable biomarker for the diagnosis of HCC.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
2	Dhanasekaran R, Limaye A and Cabrera R: Hepatocellular carcinoma: Current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepat Med. 4:19–37. 2012.PubMed/NCBI
3	Wang CH, Wey KC, Mo LR, Chang KK, Lin RC and Kuo JJ: Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma. Asian Pac J Cancer Prev. 16:3595–3604. 2015. View Article : Google Scholar : PubMed/NCBI
4	Arslanoglu A, Seyal AR, Sodagari F, Sahin A, Miller FH, Salem R and Yaghmai V: Current guidelines for the diagnosis and management of hepatocellular carcinoma: A comparative review. AJR Am J Roentgenol. 207:W88–W98. 2016. View Article : Google Scholar : PubMed/NCBI
5	Wang Y, Jing W, Ma W, Liang C, Chai H and Tu J: Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma. Cancer Biomark. 2018. View Article : Google Scholar
6	Tateishi R, Yoshida H, Matsuyama Y, Mine N, Kondo Y and Omata M: Diagnostic accuracy of tumor markers for hepatocellular carcinoma: A systematic review. Hepatol Int. 2:17–30. 2008. View Article : Google Scholar : PubMed/NCBI
7	Ferenci P, Fried M, Labrecque D, Bruix J, Sherman M, Omata M, Heathcote J, Piratsivuth T, Kew M, Otegbayo JA, et al: World gastroenterology organisation guideline. Hepatocellular carcinoma (HCC): A global perspective. J Gastrointestin Liver Dis. 19:311–317. 2010.PubMed/NCBI
8	Earl TM and Chapman WC: Conventional surgical treatment of hepatocellular carcinoma. Clin Liver Dis. 15(353–370): vii–x. 2011.
9	Li L, Lei Q, Zhang S, Kong L and Qin B: Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis. Oncol Rep. 38:2607–2618. 2017. View Article : Google Scholar : PubMed/NCBI
10	Ponting CP, Oliver PL and Reik W: Evolution and functions of long noncoding RNAs. Cell. 136:629–641. 2009. View Article : Google Scholar : PubMed/NCBI
11	Mercer TR, Dinger ME and Mattick JS: Long non-coding RNAs: insights into functions. Nat Rev Genet. 10:155–159. 2009. View Article : Google Scholar : PubMed/NCBI
12	Isin M and Dalay N: LncRNAs and neoplasia. Clin Chim Acta. 444:280–288. 2015. View Article : Google Scholar : PubMed/NCBI
13	He T, Zhang L, Kong Y, Huang Y, Zhang Y, Zhou D, Zhou X, Yan Y, Zhang L, Lu S, et al: Long non-coding RNA CASC15 is upregulated in hepatocellular carcinoma and facilitates hepatocarcinogenesis. Int J Oncol. 51:1722–1730. 2017. View Article : Google Scholar : PubMed/NCBI
14	Zheng ZK, Pang C, Yang Y, Duan Q, Zhang J and Liu WC: Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma. J Int Med Res. 46:348–356. 2018. View Article : Google Scholar : PubMed/NCBI
15	Sui J, Yang X, Qi W, Guo K, Gao Z, Wang L and Sun D: Long non-coding RNA linc-USP16 functions as a tumour suppressor in hepatocellular carcinoma by regulating PTEN expression. Cell Physiol Biochem. 44:1188–1198. 2017. View Article : Google Scholar : PubMed/NCBI
16	Hao QQ, Chen GY, Zhang JH, Sheng JH and Gao Y: Diagnostic value of long noncoding RNAs for hepatocellular carcinoma: A PRISMA-compliant meta-analysis. Medicine (Baltimore). 96:e74962017. View Article : Google Scholar : PubMed/NCBI
17	Zhu J, Liu S, Ye F, Shen Y, Tie Y, Zhu J, Jin Y, Zheng X, Wu Y and Fu H: The long noncoding RNA expression profile of hepatocellular carcinoma identified by microarray analysis. PloS One. 9:e1017072014. View Article : Google Scholar : PubMed/NCBI
18	Tang J, Jiang R, Deng L, Zhang X, Wang K and Sun B: Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma. Oncotarget. 6:4505–4515. 2015. View Article : Google Scholar : PubMed/NCBI
19	Cui H, Zhang Y, Zhang Q, Chen W, Zhao H and Liang J: A comprehensive genome-wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma. Cancer Med. 6:2932–2941. 2017. View Article : Google Scholar : PubMed/NCBI
20	You J, Fang N, Gu J, Zhang Y, Li X, Zu L and Zhou Q: Noncoding RNA small nucleolar RNA host gene 1 promote cell proliferation in nonsmall cell lung cancer. Indian J Cancer. 3 Suppl 51:e99–e102. 2014. View Article : Google Scholar
21	Yu F, Bracken CP, Pillman KA, Lawrence DM, Goodall GJ, Callen DF and Neilsen PM: p53 Represses the oncogenic sno-MiR-28 derived from a snoRNA. PloS One. 10:e01291902015. View Article : Google Scholar : PubMed/NCBI
22	Zhang M, Wang W, Li T, Yu X, Zhu Y, Ding F, Li D and Yang T: Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis. Biomed Pharmacother. 80:73–79. 2016. View Article : Google Scholar : PubMed/NCBI
23	Liu M, Xing LQ and Liu YJ: A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers. Medicine (Baltimore). 96:e62222017. View Article : Google Scholar : PubMed/NCBI
24	Page RD: TreeView: An application to display phylogenetic trees on personal computers. Comput Appl Biosci. 12:357–358. 1996.PubMed/NCBI
25	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
26	Chaiteerakij R, Addissie BD and Roberts LR: Update on biomarkers of hepatocellular carcinoma. Clin Gastroenterol Hepatol. 13:237–245. 2015. View Article : Google Scholar : PubMed/NCBI
27	Benson AB III, Abrams TA, Ben-Josef E, Bloomston PM, Botha JF, Clary BM, Covey A, Curley SA, D'Angelica MI, Davila R, et al: NCCN clinical practice guidelines in oncology: Hepatobiliary cancers. J Natl Compr Canc Netw. 7:350–391. 2009. View Article : Google Scholar : PubMed/NCBI
28	Kong FY, Xu BY, Du Y, Xu JJ and Chen HY: A branched electrode based electrochemical platform: Towards new label-free and reagentless simultaneous detection of two biomarkers. Chem Commun (Camb). 49:1052–1054. 2013. View Article : Google Scholar : PubMed/NCBI
29	Ma X, Wang X, Yang C, Wang Z, Han B, Wu L and Zhuang L: DANCR acts as a diagnostic biomarker and promotes tumor growth and metastasis in hepatocellular carcinoma. Anticancer Res. 36:6389–6398. 2016. View Article : Google Scholar : PubMed/NCBI
30	Jing W, Gao S, Zhu M, Luo P, Jing X, Chai H and Tu J: Potential diagnostic value of lncRNA SPRY4-IT1 in hepatocellular carcinoma. Oncol Rep. 36:1085–1092. 2016. View Article : Google Scholar : PubMed/NCBI
31	Yuan W, Sun Y, Liu L, Zhou B, Wang S and Gu D: Circulating LncRNAs serve as diagnostic markers for hepatocellular carcinoma. Cell Physiol Biochem. 44:125–132. 2017. View Article : Google Scholar : PubMed/NCBI
32	Zhang H, Zhou D, Ying M, Chen M, Chen P, Chen Z and Zhang F: Expression of long non-coding RNA (lncRNA) small nucleolar RNA host gene 1 (SNHG1) exacerbates hepatocellular carcinoma through suppressing miR-195. Med Sci Monit. 22:4820–4829. 2016. View Article : Google Scholar : PubMed/NCBI
33	Yang SL, Liu LP, Yang S, Liu L, Ren JW, Fang X, Chen GG and Lai PB: Preoperative serum α-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma. Br J Surg. 103:716–724. 2016. View Article : Google Scholar : PubMed/NCBI
34	Sahu D, Hsu CL, Lin CC, Yang TW, Hsu WM, Ho SY, Juan HF and Huang HC: Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma. Oncotarget. 7:58022–58037. 2016. View Article : Google Scholar : PubMed/NCBI
35	Wang J, Cao L, Wu J and Wang Q: Long non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326 and promotes tumorigenesis in osteosarcoma. Int J Oncol. 52:77–88. 2018.PubMed/NCBI
36	Zhang Y, Jin X, Wang Z, Zhang X, Liu S and Liu G: Downregulation of SNHG1 suppresses cell proliferation and invasion by regulating notch signaling pathway in esophageal squamous cell cancer. Cancer Biomark. 21:89–96. 2017. View Article : Google Scholar : PubMed/NCBI